The frequencies of this fusion event decreased from the adjacent tissues (29.2%) to tumors the (16.7%), suggesting that a truncated thymidine Kinase1 (TK1) caused by the fusion event might be deleterious and be selected against during tumor progression. This evidence concerns the gene TK1 and neoplasm.